Blood eosinophils in COPD: long term variability and clinical outcomes

G. Turato (Padova, PD, Italy)

Source: International Congress 2017 – Innovation in COPD: techniques and facts
Session: Innovation in COPD: techniques and facts
Session type: Oral Presentation
Number: 492
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Turato (Padova, PD, Italy). Blood eosinophils in COPD: long term variability and clinical outcomes. 492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Longitudinal measurements of blood eosinophils in relation to COPD outcomes
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Impact of blood eosinophil variability in asthma: a real-life population study.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Stability of blood eosinophils over time in patients with asthma
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD
Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019
Year: 2020



Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


COPD treatment choices based on blood eosinophils: are we there yet?
Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019
Year: 2019



Within-day variability of blood eosinophils in stable COPD patients: a prospective trial.
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis
Source: International Congress 2017 – Management of COPD
Year: 2017

Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Serial blood eosinophils and clinical characteristics in COPD patients without a history of asthma or atopy
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Blood eosinophilia in patients with COPD, a real life evaluation
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018




The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016


Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016